




Searching News Database: TELIGEN
HSMN NewsFeed - 14 Feb 2018
Teligent, Inc. Announces FDA Approval of Betamethasone Dipropionate Lotion USP (Augmented), 0.05%
Teligent, Inc. Announces FDA Approval of Betamethasone Dipropionate Lotion USP (Augmented), 0.05%
HSMN NewsFeed - 15 Aug 2017
Pharmalink Strengthens Its Management Team. Appoints New Chief Financial Officer and Head of Communications
Pharmalink Strengthens Its Management Team. Appoints New Chief Financial Officer and Head of Communications
HSMN NewsFeed - 21 Jul 2017
Teligent, Inc. Announces FDA Approval Of Erythromycin Topical Gel USP, 2%
Teligent, Inc. Announces FDA Approval Of Erythromycin Topical Gel USP, 2%
HSMN NewsFeed - 25 Aug 2016
Teligent, Inc. Announces Health Canada Approval Of Three Baclofen Injection Products
Teligent, Inc. Announces Health Canada Approval Of Three Baclofen Injection Products
HSMN NewsFeed - 8 Jul 2016
Teligent, Inc. Receives Two FDA Approvals for Topical Prescription Portfolio
Teligent, Inc. Receives Two FDA Approvals for Topical Prescription Portfolio
HSMN NewsFeed - 11 Dec 2015
Teligent, Inc. Announces FDA Approval Of CEFOTAN(R) (cefotetan) For Injection
Teligent, Inc. Announces FDA Approval Of CEFOTAN(R) (cefotetan) For Injection
HSMN NewsFeed - 31 May 2012
Boston Scientific Increases Longevity Projections for Its U.S. Defibrillators
Boston Scientific Increases Longevity Projections for Its U.S. Defibrillators
HSMN NewsFeed - 23 Feb 2012
Boston Scientific Announces First Implants of TELIGEN(R) Implantable Defibrillator in China
Boston Scientific Announces First Implants of TELIGEN(R) Implantable Defibrillator in China
HSMN NewsFeed - 13 Jul 2009
Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System
Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System
HSMN NewsFeed - 13 May 2008
Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
HSMN NewsFeed - 22 Feb 2008
Sucampo Pharmaceuticals Appoints John C. Wright, Retired Ernst & Young Partner, to Board of Directors
Sucampo Pharmaceuticals Appoints John C. Wright, Retired Ernst & Young Partner, to Board of Directors
HSMN NewsFeed - 22 Jan 2008
Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death